WHO Obesity Agenda: Addiction Vaccines & Resource Management
June 28, 2013
The World Health Organization (WHO) European Office released a report decrying the marketing techniques used to coerce children into wanting foods high in trans fats, saturated fats, refined sugar and salt which contributes to obesity.
Zsuzsanna Jakab, director for the European office of WHO stated in a press release: “Millions of children across the European Region are subjected to unacceptable marketing practices. Policy simply must catch up and address the reality of an obese childhood in the 21st century. Children are surrounded by adverts urging them to consume foods high in fat, sugar and salt, even when they are in places where they should be protected, such as schools and sports facilities.”
In 2010, WHO outlined rules for nations to admonish corporations who market to children – especially with regard to unhealthy food.
Since television is influential, adverts directed at children must be controlled; as well as how many hours a day kids are allowed to watch TV. WHO states that children should watch no more than 2 hours per day.
The Centers for Disease Control and Prevention (CDC) warned that since obesity in children has tripled over the last 30 years, a lifetime of chronic illness including type 2 diabetes will place a drag on medical insurance and the cost of care for all.
Obesity being a diease facilitates pharmacological treatment. Research into addiction vaccines could be the next step in this scheme.
Last year, WHO stated that because of over-population and over-consumptive cultures, Americans have become overweight . . . and that is a problem.
Working with WHO, researchers at the BMC Public Health have published a study regarding the increasing levels of “fatness” worldwide and the impact such weight gain has on global resources. They contend that over-weight people are likening to an extra billion humans born on the planet.
The target of these researchers is North America, specifically the American population. Although Americans only account for 6% of the global population, more than a third of them are considered obese. They contend a new social meme concerning consumption, weight and population growth called “globesity” must be introduced to combat this new problem.
Prof Charles Godray from the Martin School at the University of Oxford, who chaired the process of writing the declaration, says “The overall message is that we need a renewed focus on both population and consumption – it’s not enough to look at one or the other. We need to look at both, because together they determine the footprint on the world.”
Kim Janda, professor of chemistry for the Scripps Research Institute (SRI) explains that the development of a vaccine to combat addictions is an “alternative or better way for some people . . . to get off the drugs.”
Janda believes that by shutting down the neuroreceptor that responds to the chemical nicotine before it affects the chemical responders in the brain. These vaccines cause the immune system to produce antibodies that control the brain’s response to narcotics prior to the onset of addiction. This is based on the hypothesis that addiction causes physical changes in the brain and has spurned medical advocacy for solving America’s drug problems with immunizations.
Under the guise of controlling our brain functions, other vaccines that mitigate the reward centers of the human brain are being created – such as a vaccine that stops crystal meth molecules from entering the blood brain barrier so that the drug-user does not get “high”.
Alkernes Inc. have developed the pharmaceutical vivitrol which is a once-a-month injection that blocks the brain’s reward system for alcoholics and opioid addicts.
Similarly, Pfizer has created Chantix; a pill that disrupts the brain’s pleasure centers regarding nicotine. Chantix is known to cause suicidal thoughts and depression in its users, although Pfizer contends that there is no direct scientific link to depression and their drug.
Xenova, a British-based biotechnology corporation, has invested in vaccines that control cocaine addiction. After a two-phase study, their drug had a reported 58% success rate. The vaccine alters the human immune system by removing the biological response to cocaine molecules, preventing their ability to cross the blood-brain barrier and therefore stifling their ability to influence pleasure in the drug user.
Another professor from the SRI, Michael Taffe says that his study results, although early “are comparable to those for other drug vaccines that have then gone to clinical trials.”
The SRI pride themselves on having a “philosophy [that] emphasizes the creation of basic knowledge in the biosciences for its application in medicine, the pursuit of fundamental scientific advances through interdisciplinary programs and collaborations, and the education and training of researchers preparing to meet the scientific challenges of the future.”
SRI works with the US government through institutions like the National Institute of Medicine. Their medical endeavors extend to researching vaccinations to treat addiction, HIV/AIDS, H1N1, Obesity, cancer synthesis and polio.
The founder of SRI, Ellen Browning Scripps (EBS), was a eugenicist, in-conjunction with the E.W. Scripps Company. EBS focused research on understand human metabolic rates with the inception of the Scripps Metabolic Clinic.
Most recently, the SRI was awarded a $1.9 million grant from the National Institutes of Health (NIH) to study human food necessity and the metabolism. Andrew Butler, professor at the SRI, is finding the neuro-pathways that control the brain’s desire for food throughout the day. By rewiring the brain’s requests for food and the body response to those requests, the amount of food consumed would potentially be considerably less.